Investor
The company plans to use the new money to invest in its data and building out its products.
An R&D cloud platform which supports scientists to share and access progress with the development of biopharmaceutical therapeutics has raised $35 million in investment capital.
DrugStoc scooped up $4.4 million in funding, and African Health Holdings landed $18 million.
Pear announced plans to go public through a merger with a special purpose acquisition company in June, and the deal is set to close soon.
Led by Nour Nouf Ventures, the round will be dedicated to scaling, plus research and development efforts, the startup announced.
Also: Amwell misses revenue expectations and Babylon Health grows 371% year-over-year.
The Series B brings the company’s total raise to $71 million.
Also: Remote patient monitoring platform HealthSnap brings in $5 million, and behavioral health-focused Videra Health raises a $3 million seed round.
This new funding round brings the company's total raise to roughly $62.5 million.
The clinical trial results will be used to expand Viome’s mRNA platform, which in May received FDA breakthrough device designation for identifying early signs of oral and throat cancers.